How can Recce justify such significant increases in remuneration for its executives?
Total remuneration up 73%
Total employee benefits expense up 78%
James and Michelle's base remuneration up over 60% each.
Travel costs nearly $1 million yet Recce has focussed its trials etc in Australia.
Current operations are now being funded via debt from Radium Capital.
At 30 June 2023 the company had significant negative net assets, what a disaster.
Financially, management appears to be out of their depth.
Surely it is time for an experienced CEO to be appointed!!!
- Forums
- ASX - By Stock
- Ann: Appendix 4E and Unaudited Preliminary Report
RCE
recce pharmaceuticals ltd
Add to My Watchlist
6.15%
!
30.5¢

How can Recce justify such significant increases in remuneration...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
30.5¢ |
Change
-0.020(6.15%) |
Mkt cap ! $87.95M |
Open | High | Low | Value | Volume |
32.5¢ | 33.0¢ | 30.5¢ | $27.88K | 88.04K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 41218 | 30.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.5¢ | 69366 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 41218 | 0.305 |
7 | 31464 | 0.300 |
2 | 10000 | 0.295 |
11 | 90433 | 0.290 |
2 | 135000 | 0.285 |
Price($) | Vol. | No. |
---|---|---|
0.315 | 72880 | 2 |
0.320 | 523 | 1 |
0.325 | 523 | 1 |
0.330 | 93238 | 1 |
0.335 | 302 | 1 |
Last trade - 12.20pm 18/06/2025 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |
The Watchlist
CDE
CODEIFAI LIMITED
John Houston / Martin Ross, Executive Chairman / COO
John Houston / Martin Ross
Executive Chairman / COO
Previous Video
Next Video
SPONSORED BY The Market Online